Rene Russo

Insider Reports History

Location
C/O Arsanis, Inc., 890 Winter Street, Suite 230, Waltham, MA
Signature
/s/ Kevin Brennan, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Rene Russo:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Adagio Therapeutics, Inc. Director Common Stock 1.99M $7.84M $3.95 Aug 5, 2021 Direct
Xilio Therapeutics, Inc. PRESIDENT AND CEO, Director Common Stock 281K $191K $0.68 Jun 16, 2025 Direct
Xilio Therapeutics, Inc. PRESIDENT AND CEO, Director Restricted Stock Units 133K $138K $1.04 Jan 1, 2025 Direct
X4 Pharmaceuticals, Inc Director Stock Option (right to buy) 6K $7.68K $1.28 Jun 2, 2021 Direct
Xilio Therapeutics, Inc. PRESIDENT AND CEO, Director Stock Option (right to buy) 190K Apr 15, 2025 Direct
Adagio Therapeutics, Inc. Director Stock Option (Right to Buy) 35.6K Aug 5, 2021 Direct

Insider Reports Filed by Rene Russo

Symbol Company Period Transactions Value $ Form Type Date Filed Role
XLO Xilio Therapeutics, Inc. Jun 16, 2025 1 $24.7K 4 Jun 18, 2025 PRESIDENT AND CEO, Director
XLO Xilio Therapeutics, Inc. Apr 15, 2025 1 $0 4 Apr 16, 2025 PRESIDENT AND CEO, Director
XLO Xilio Therapeutics, Inc. Jan 1, 2025 0 $0 4/A Jun 18, 2025 PRESIDENT AND CEO, Director
XLO Xilio Therapeutics, Inc. May 1, 2024 1 $0 4 May 3, 2024 PRESIDENT AND CEO, Director
XLO Xilio Therapeutics, Inc. Jan 1, 2024 1 $0 4 Jan 3, 2024 PRESIDENT AND CEO, Director
XLO Xilio Therapeutics, Inc. Aug 16, 2023 1 $0 4 Aug 18, 2023 CEO, Director
XLO Xilio Therapeutics, Inc. Jan 1, 2023 1 $0 4 Jan 4, 2023 CEO, Director
XLO Xilio Therapeutics, Inc. Feb 22, 2022 1 $0 4 Feb 24, 2022 CEO AND PRESIDENT, Director
XLO Xilio Therapeutics, Inc. Dec 22, 2021 1 $0 4/A Jan 4, 2022 CEO AND PRESIDENT, Director
XLO Xilio Therapeutics, Inc. Oct 21, 2021 1 $0 4 Oct 25, 2021 CEO and President, Director, 10%+ Owner
XLO Xilio Therapeutics, Inc. Oct 21, 2021 0 $0 3 Oct 21, 2021 CEO and President, Director, 10%+ Owner
IVVD Adagio Therapeutics, Inc. Aug 5, 2021 1 $0 4 Aug 9, 2021 Director
IVVD Adagio Therapeutics, Inc. Aug 5, 2021 0 $0 3 Aug 5, 2021 Director
XFOR X4 Pharmaceuticals, Inc Jun 2, 2021 1 $57K 4 Jun 2, 2021 Director